ZhuXLiangJLiFYangYXiangLXuJ.Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int J Dermatol2011; 50: 697–704.
2.
LuoYLiYSuY. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol2008; 159: 827–833.
3.
Wei-MinSZhou-WeiWXing-YuM. The effect of DNMTs and MBPs on hypomethylation in systemic lupus erythematosus. J Dermatol Sci2009; 53: 236–238.
4.
BogdanovicOVeenstraGJ.DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma2009; 118: 549–565.
5.
ZhaoSLongHLuQ.Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol2010; 39: 3–9.
6.
HochbergMC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
BaladaEOrdi-RosJSerrano-AcedoSMartinez-LostaoLVilardell-TarresM.Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol2007; 81: 1609–1616.
9.
LeiWLuoYYanK. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol2009; 38: 369–374.
10.
LiuCCOuTTWuCC. Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus. Lupus2011; 20: 131–136.